Tag: Venetoclax

AbbVie’s ibrutinib, venetoclax combo succeeds in phase 3 GLOW study

pallavi123- June 13, 2021

AbbVie said that the phase 3 GLOW study in chronic lymphocytic leukemia (CLL) investigating the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax) (I+V) has met ... Read More

Tolero, AbbVie to explore venetoclax alvocidib combo for AML

pharmanewsdaily- August 19, 2018

Tolero Pharmaceuticals said that its cyclin-dependent kinase 9 (CDK9) inhibitor alvocidib will be combined with AbbVie leukemia drug venetoclax to evaluate their potential in their ... Read More